Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Allopregnanolone changes gene expression in glioblastoma cells.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Fenugreek leaf extracts significantly promoted hair growth in mice with alopecia.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.